In bladder cancer, the overexpression of TRIM29 suppresses miR-29 and subsequently activates DNA methyltransferase 3A (DNMT3A), resulting in DNA methylation and silencing of tumor suppressor PTEN (30–32). Here, TRIM29 is linked to urinary bladder carcinoma.